Skip to content

Effect of tDCS Combined With Sensorimotor Training on Sensorimotor Function after Stroke

Effect of tDCS Combined With Sensorimotor Training on Sensorimotor Function after Stroke

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100052663
Enrollment
Unknown
Registered
2021-11-03
Start date
2021-11-02
Completion date
Unknown
Last updated
2022-08-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

experimental group:tDCS combined with sensorimotor training
control group:Sham tDCS combined with sensorimotor training

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients with first-time, unilateral cerebral hemisphere cerebral infarction confirmed by cranial computed tomography (CT) or magnetic resonance (MRI) examination (diagnosed in accordance with the "China Various Types of Cerebral Vascular Diseases Group" formulated by the Chinese Medical Association Neurology Branch Main points of diagnosis of cerebrovascular disease 2019 "Consensus); 2. Aged 30 to 70 years; male or female; 3. The course of the disease is 14 days after the onset; patients with stable disease; 4. There is hemiplegia and/or hemisensory disorder (at least one of the sensory functions of superficial sensation, proprioception and complex sensation is impaired at the time of screening); 5. No cognitive impairment, able to execute simple commands (Minimum Mental State Score MMSE>21); 6. Voluntarily participate in this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Difficulty in communication, with aphasia or severe dysarthria; 2. Moderate to severe spasticity of each affected limb (modified Ashworth score >= 2); 3. Severe visual impairment (visual acuity < 0.3); 4. Traumatic brain injury or brain tumor; 5. Intracranial metal implants; 6. Serious medical diseases (pacemaker, liver and kidney insufficiency, infectious diseases, etc.); 7. The patient has a history of epilepsy or a family history of epilepsy.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Upper Limb Motor Function Scale;Modified Nottingham Sensory Function Scale;

Secondary

MeasureTime frame
Upper Limb Movement Research Scale;joint range of motion assessment;

Countries

China

Contacts

Public ContactLi Chong

Huashan Hospital, Fudan University

lichongsus@163.com+86 13218553655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026